251 related articles for article (PubMed ID: 24916363)
1. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
2. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
3. Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.
Wilson-Poe AR; Jeong HJ; Vaughan CW
J Physiol; 2017 Oct; 595(20):6541-6555. PubMed ID: 28815604
[TBL] [Abstract][Full Text] [Related]
4. Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.
Lau BK; Winters BL; Vaughan CW
Br J Pharmacol; 2020 May; 177(10):2320-2332. PubMed ID: 31971607
[TBL] [Abstract][Full Text] [Related]
5. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
Hoffman AF; Lupica CR
J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
[TBL] [Abstract][Full Text] [Related]
6. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
Vaughan CW; Connor M; Bagley EE; Christie MJ
Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
[TBL] [Abstract][Full Text] [Related]
7. DAMGO depresses inhibitory synaptic transmission via different downstream pathways of μ opioid receptors in ventral tegmental area and periaqueductal gray.
Zhang W; Yang HL; Song JJ; Chen M; Dong Y; Lai B; Yu YG; Ma L; Zheng P
Neuroscience; 2015 Aug; 301():144-54. PubMed ID: 26047721
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Mitchell VA; Kawahara H; Vaughan CW
J Physiol; 2009 Jun; 587(Pt 11):2511-20. PubMed ID: 19359367
[TBL] [Abstract][Full Text] [Related]
9. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Vaughan CW; Bagley EE; Drew GM; Schuller A; Pintar JE; Hack SP; Christie MJ
Br J Pharmacol; 2003 May; 139(2):362-7. PubMed ID: 12770941
[TBL] [Abstract][Full Text] [Related]
10. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
11. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
Bagley EE; Chieng BC; Christie MJ; Connor M
Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
13. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray.
Lau BK; Vaughan CW
Mol Pharmacol; 2008 Nov; 74(5):1392-8. PubMed ID: 18678620
[TBL] [Abstract][Full Text] [Related]
15. Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.
Xiao C; Ye JH
Neuroscience; 2008 Apr; 153(1):240-8. PubMed ID: 18343590
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro.
Vaughan CW; Christie MJ
J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):463-72. PubMed ID: 9032693
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
Kow LM; Commons KG; Ogawa S; Pfaff DW
Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477
[TBL] [Abstract][Full Text] [Related]
18. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
Connor M; Bagley EE; Chieng BC; Christie MJ
Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
Mitchell VA; Jeong HJ; Drew GM; Vaughan CW
Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
[TBL] [Abstract][Full Text] [Related]
20. Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.
Bajo M; Roberto M; Madamba SG; Siggins GR
Addict Biol; 2011 Oct; 16(4):551-64. PubMed ID: 21182569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
